Cytotoxicity Testing
Various cytotoxicity testing are available to characterize medical device components or materials. These in-vitro test methods are an easy and economical tool in assessing candidate new materials as well as assuring lot to lot acceptability of polymers and plastics used in medical devices.
Our Tests
B300
Direct Contact, Cell Culture Assay, 24 hour incubation, triplicate L929 cells
B301
Agar Overlay, Cell Culture Assay, 24 hour incubation, triplicate L929 cells
B302
MEM Elution Method, 48 hour incubation, triplicate L929 cells
B302A
MEM Elution Method, 72 hour incubation, triplicate L929 cells
B302B
MEM Elution with end point titration
Sample Submission
Purchase Order
In line with current ISO/QSR purchasing requirements, all orders should be sent with a signed completed Purchase Order. This will help expedite the processing or your order. Standing Purchase Orders will be gladly accepted for routine continuing orders.
Sample Submission Form
Final Reports
Upon completion of test, a final report will be issued and all records and raw data will be held for five years.
USP 88 In-Vivo Cytotoxicity Testing
Learn what USP 88 cytotoxicity tests are available and which ones you will need to meet the regulatory requirements for your medical devices.
USP 87 In-Vitro Cytotoxicity Testing
Learn what USP 87 cytotoxicity tests are available and which ones you will need to meet the regulatory requirements for medical products.
In-Vitro USP 87 Vs. In-Vivo USP 88 Cytotoxicity Testing
Learn about in-vitro vs. in-vivo medical device cytotoxicity assessments, and requirements of USP 87 and USP 88.
